SequelSEC

Odyssey Health, Inc. ODYY

Surgical & Medical Instruments & Apparatus · CIK 0001626644 · Fiscal year ends 0731

AnnualQuarterlyTTM
Revenue
$0
Fiscal year ended 2020-07-31
Operating income
-$3.85M
Fiscal year ended 2020-07-31
Free cash flow
Unavailable
Fiscal year ended 2020-07-31

Odyssey Health, Inc. (ODYY) reported revenue of $0 and net income of -$4.35M for the fiscal year ended 2020-07-31. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Odyssey Health, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

Odyssey Health, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2020-07-31
Revenue$0
Cost of revenue$0
Gross profit$0
Operating income-$3.85M
Net income-$4.35M
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax incomeUnavailable
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrativeUnavailable
General & administrative$3.85M
Selling & marketingUnavailable

Balance

Odyssey Health, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2020-07-31
Cash & equivalents$62.95K
Total assets$105.58K
Current assets$99.62K
Total liabilities$757.06K
Current liabilities$707.06K
Total equity incl. NCI-$651.48K
Temporary (mezzanine) equityUnavailable
InventoryUnavailable
Accounts receivableUnavailable
GoodwillUnavailable
Long-term debt$50.00K
Accounts payable$269.39K

Cash flow

Odyssey Health, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2020-07-31
Operating cash flow-$649.14K
Capital expendituresUnavailable
Investing cash flowUnavailable
Financing cash flow$545.00K
Net change in cash-$104.14K
Stock-based compensation$2.78M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$10.55K

Derived

Odyssey Health, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2020-07-31
Free cash flowUnavailable
Gross marginUnavailable
Operating marginUnavailable
FCF marginUnavailable
SBC / revenueUnavailable
Current ratio0.14x
Revenue YoY growthUnavailable
Net marginUnavailable
R&D / revenueUnavailable
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open ODYY in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-06-12View SEC filing
10-Q · Filed 2026-03-12View SEC filing
10-Q · Filed 2025-12-11View SEC filing
10-K · Filed 2025-10-29View SEC filing
10-Q · Filed 2025-06-13View SEC filing
10-Q · Filed 2025-03-14View SEC filing

Companies in the same industry

ADGM AEMD ALUR AMIX ANGO ANIK AORT APYX ARAY ATEC ATRC AURX

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.